Cancer-eInfo

Your gateway to the latest information from both medical and alternative sources

                                                                                                       

FREE Healthy Eating Course                                                           Home     Contact Us

Designed to coach you towards better health

 

                                      

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Glenn & Marilyn

 

Renal Cancer

 

Although our experience was with another type of cancer, our research leads us to believe that our conclusions are just as applicable to renal cancer.

 

What we found was an explanation as to why cancerous tumours develop and the nutritional requirements needed to enable the body to fight them.  Using this information, we formulated an approach based on nutrition and reducing toxins.  This approach lead to a complete recovery from cancer in eleven months, without surgery.

 

As a result of many people asking for details of what we had learned, we finally wrote a book about our experience. 

It can be accessed by clicking on this link.

Please tell me more about the eBook

 

Alternatively, please find below the latest information to further your research on renal cancer.

 

Molecule That Kills Kidney Cancer Cells Discovered - Science Daily (press release)

Molecule That Kills Kidney Cancer Cells Discovered
Science Daily (press release) - Jul 7, 2008
His findings will be published in the journal Cancer Cell on July 8. Giaccia said his lab focused on renal cell carcinoma, or kidney cancer, because there ...
Kidney Cancer Cells Tricked Into Killing Themselves NPR
Can Recycling Be Used To Treat Cancer? Science Daily (press release)
all 31 news articles

NEJM Publishes Nexavar® (sorafenib) Study Demonstrating Major ... - Medical News Today (press release)

NEJM Publishes Nexavar® (sorafenib) Study Demonstrating Major ...
Medical News Today (press release), UK - Jul 25, 2008
Sorafenib is approved in the UK for the treatment of patients with advanced renal cell carcinoma (the most common form of kidney cancer), who have failed ...

ORLive Presents: Radiofrequency Ablation of a Kidney Tumor - MarketWatch

ORLive Presents: Radiofrequency Ablation of a Kidney Tumor
MarketWatch - Jul 21, 2008
"These results are significant and encouraging because the incidence of kidney cancer in the United States has increased by 126 percent over the past 50 ...

Molecule That Kills Kidney Cancer - Oneindia

Oneindia

Molecule That Kills Kidney Cancer
Oneindia, India - Jul 10, 2008
"There is no effective chemotherapy to treat renal cell carcinoma. Patients still succumb," said Giaccia, also a researcher at the Stanford Cancer Center. ...

Molecule Uses Cellular Recycling to Treat Kidney Cancer - U.S. News & World Report

Molecule Uses Cellular Recycling to Treat Kidney Cancer
U.S. News & World Report, DC - Jul 7, 2008
In this study, Giaccia and his colleagues focused on renal cell carcinoma (RCC), the most common form of kidney cancer. In most cases, RCC is caused by a ...

Kidney Cancer Progression Slowed by mTOR Inhibitor - MedPage Today

Kidney Cancer Progression Slowed by mTOR Inhibitor
MedPage Today, NJ - Jul 23, 2008
The findings suggest that failure of targeted therapy does not signal the end of the therapeutic road for patients with metastatic renal cell cancer. ...

BioMedica says TroVax renal cancer study disappoints - Reuters

BioMedica says TroVax renal cancer study disappoints
Reuters - Jul 11, 2008
... Data Safety Monitoring Board had advised it that a final stage clinical trial of its TroVax drug in renal cancer would not meet its main goal. ...
Cancer study hits Oxford Bio Financial Times (subscription)
Sanofi, Oxford BioMedica Say Cancer Drug Won't Meet Study Goal Bloomberg
Shares in Oxford Biomedica plummet on drug trial failure Times Online
Reuters - Times Online
all 56 news articles

Everolimus Improves Survival with Advanced Renal Cancer - Cancerpage.com

Everolimus Improves Survival with Advanced Renal Cancer
Cancerpage.com, GA - Jul 23, 2008
This finding stems from a study of 410 patients with metastatic renal cancer that had progressed on sunitinib, sorafenib, or both drugs. ...

 

            

                      Home          Privacy           Legal Disclaimer           Contact Us